Midatech Pharma Share Discussion Threads

[shujja1] 02/5/2022 02:49

Gibson what kind of news you expecting please explain

[guy gibson] 14/4/2022 12:41

I suspect there will be a few RNSs published very soon.

[guy gibson] 14/4/2022 12:39

Midatech Pharma PLC

14 April 2022

14 April 2022

Midatech Pharma PLC

("Midatech" or the "Company"")

Receipt of NASDAQ Notice

Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it received written notification (the "Notification Letter") from The NASDAQ Stock Market LLC ("NASDAQ"), dated 13 April 2022, stating that the Company is not in compliance with the minimum bid price requirement set forth in NASDAQ's rules for continued listing on The NASDAQ Capital Market. NASDAQ Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's American Depositary Shares (the "Depositary Shares"), each representing five ordinary shares of the Company, for the 30 consecutive business days beginning 2 March 2022, the Company no longer meets the minimum bid price requirement.

The Notification Letter has no immediate effect on the listing of the Depositary Shares, and they will continue to trade on The NASDAQ Capital Market under the symbol "MTP."

In accordance with NASDAQ Listing Rule 5810(c)(3)(A), the Company has a grace period of 180 calendar days, or until 10 October 2022 (the "Compliance Period"), to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Depositary Shares must meet or exceed $1.00 per share for at least 10 consecutive business days during the Compliance Period. If the Depositary Shares do not regain compliance with the minimum bid price requirement during the Compliance Period, the Company may be eligible for an additional grace period of 180 calendar days provided that the Company satisfies NASDAQ's initial listing standards for listing on The NASDAQ Capital Market, other than the minimum bid price requirement, and provides written notice to NASDAQ of its intention to cure the delinquency during the second grace period. If the Company does not regain compliance during the initial grace period and is not eligible for an additional grace period, NASDAQ will provide written notice that the Depositary Shares are subject to delisting from The NASDAQ Capital Market. In that event, the Company may appeal such determination to a hearing panel.

The Company intends to monitor the bid price of its Depositary Shares during the Compliance Period and will consider taking such actions as may be necessary and appropriate to achieve compliance with continued listing requirements prior to the expiration of all available grace periods.

The Company's business operations are not affected by the receipt of the Notification Letter.

The Company's ordinary shares are listed on the AIM Market of the London Stock Exchange, and the Notification Letter does not affect the Company's compliance status with such listing.

[robsy2] 06/4/2022 11:15

David
How much stock is normally on offer here?

[david gruen] 06/4/2022 10:56

Managed to buy a few more (not showing yet). Not easy.

Plenty of news to flow this year. Cash until the end of the year so no brainer to hold at these levels until at least the end of summer.

You know how quickly this can move.

[zen12] 05/4/2022 11:54

Can buy now just about...?

[tomboyb] 05/4/2022 10:41

Most of it is guesswork when you go below 3% unless you have the tenacity to count trades -

NT at 14p and yes, it isn't 100% the seller has cleared, however read my statement -

LOOKS like seller has cleared -

[enewman36] 05/4/2022 10:29

Based on what, there hasn't been a TR1 to confirm so assuming this is guess work?.

[tomboyb] 05/4/2022 09:47

Looks like seller has cleared -

[dave4545] 03/3/2022 21:35

Wonder when this is going to spring back into life.

Seems to be massive overhang with almost zero volume, today is the first time for ages volumes over 1 mil, I had a sneaky try late on and could not get a quote to buy 5000 at 13.5p so why drop the price if you are not letting anybody buy?

[pugugly] 25/1/2022 09:52

Been going down hill ever since the placing at 27P jointly by Turner Pope 25/7/20.
Could there be any value left? Unlikely (imo). But DYOR as usual

[dave4545] 20/1/2022 15:23

All time low to buy

17.6p offer, brutal overhang in this atm

[dave4545] 19/1/2022 07:46

These holding Rns's used to be so clear

I thought initially it was saying spread X is out no shares but now it's apparently
saying they have bought over 3% here

Weird these big stakes changing hands because you never see any big trades.

Anyway I've been nibbling, historically the price has done very well from 20p levels in the past but that does not guarantee it will again in the future

[oldbronze] 17/1/2022 07:46

Good News.

[shujja1] 14/1/2022 00:13

Charlie Malik (@CharliemalikMr) Tweeted:
#MTPH [...]

[chique] 07/1/2022 20:59

Canter Fitzgerald acquire 5% Iin Midatech

From Canter Fitzgerald website

US Healthcare Equities

A particular strength is our US healthcare equities team. CFE’s rated analysts have deep specialization in their respective areas. Together they span almost the entirety of the US healthcare sector and cover the full range of market capitalization. Our research capabilities are complimented by regular expert calls in both the healthcare and tech sectors. We also provide a variety of corporate access opportunities for investors.

[david gruen] 05/1/2022 14:49

Very similar to the IMM chart. Looks ready to test the top of the chanel (50p in the case of MTPH.)

[kingston78] 05/1/2022 14:47

The chart looks poised to go higher.

[oldbronze] 05/1/2022 13:50

Let's see where this goes today.

[shujja1] 29/12/2021 21:17

Charlie Malik (@CharliemalikMr) Tweeted:
#MTPH 🦅🇪🇺 PATENT Midatech Pharma has been granted European Patent No. EP2736621 by the European Patent Office, titled: DEVICE AND METHOD FOR PRODUCING AND COLLECTING BEADS. Patent will issue on Jan 26th.